Anna Rowe – Research output — University of Birmingham

Research activity per year

7 Article
6 Abstract
2 Preprint
1 Comment/debate

2 results

Filter

2021
CATALYST trial protocol: a multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
Veenith, T., Fisher, B. A., Slade, D., Rowe, A., Sharpe, R., Thickett, D. R., Whitehouse, T., Rowland, M., Scriven, J., Parekh, D., Bowden, S. J., Savage, J. S., Richards, D., Bion, J., Kearns, P. & Gates, S., 12 Feb 2021, medRxiv, p. 1-15, 15 p.
Research output: Working paper/Preprint › Preprint

Open Access
Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial
Fisher, B. A., Veenith, T., Slade, D., Gaskell, C., Rowland, M., Whitehouse, T., Scriven, J., Parekh, D., Balasubramaniam, M. S., Cooke, G., Morley, N., Gabriel, Z., Wise, M. P., Porter, J., McShane, H., Ho, L-P., Newsome, P. N., Rowe, A., Sharpe, R., Thickett, D. R., & 4 othersBion, J., Gates, S., Richards, D. & Kearns, P., 9 Jun 2021, medRxiv, p. 1-26, 26 p.
Research output: Working paper/Preprint › Preprint